No Data
No Data
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Pfizer's two new triple anti-drug therapies have been approved for clinical trials in China.
According to public information from Pfizer, both of these products are tri-specific antibodies and are new molecular entities in the company's inflammation and immune pipelines.
Pfizer Options Spot-On: On June 14th, 129.54K Contracts Were Traded, With 3.16 Million Open Interest
On June 14th ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 129.54K options for the day, of which put options accounted for 29.68% of the total transactions, and call
Pfizer Stock Traded in the Red for Seven Straight Days
Express News | FDA Says On June 13 Updates Advice To Manufacturers Of Covid-19 Vaccines (2024-2025 Formula): If Feasible Use KP.2 Strain Of JN.1-Lineage
How Is The Market Feeling About Pfizer?
Pfizer's (NYSE:PFE) short percent of float has risen 8.06% since its last report. The company recently reported that it has 75.97 million shares sold short, which is 1.34% of all regular shares that a
No Data